Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Critical Care Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00003246-199501000-00018PMID 8001395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Continuous veno‐venous hemofiltration with dialysis removes cytokines from the circulation of septic patients

  1993cited by this paper
• Does Continuous Hemodiafiltration Improve Survival in Acute Renal Failure?

  1993cited by this paper
• Role of platelet activating factor in hemodialysis.

  1993cited by this paper
• Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure

  1993cited by this paper
• Acute continuous hemodiafiltration: a prospective study of 110 patients and a review of the literature.

  1993cited by this paper
• Porins and lipopolysaccharide stimulate platelet activating factor synthesis by human mesangial cells.

  1992cited by this paper
• Pump-driven haemofiltration

  1991cited by this paper
• Pump-driven haemofiltration.

  1991cited by this paper
• Platelet-activating Factor

  1991cited by this paper
• Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock

  1991cited by this paper
• Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure.

  1991cited by this paper
• Release of platelet-activating factor in systemic lupus erythematosus.

  1990cited by this paper
• Platelet-activating factor.

  1990cited by this paper
• Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.

  1989cited by this paper
• The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells.

  1988cited by this paper
• Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

  1987cited by this paper
• Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats.

  1987cited by this paper
• Solute transport in continuous hemodialysis: a new treatment for acute renal failure.

  1987cited by this paper
• Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor

  1987cited by this paper
• Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung.

  1986cited by this paper
• Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig.

  1986cited by this paper
• Is platelet activating factor (PAF) a mediator of endotoxin shock?

  1985cited by this paper
• Synthesis of PAF-acether and blood volume changes in gram-negative sepsis.

  1985cited by this paper
• Pharmacokinetic study of3H-labelled PAF-acether II. Comparison with3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding

  1984cited by this paper
• Continuous arteriovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics.

  1983cited by this paper
• Continuous Arteriovenous Hemofiltration in the Critically Ill Patient: Clinical Use and Operational Characteristics

  1983cited by this paper
• Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.

  1983cited by this paper
• Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats.

  1983cited by this paper
• Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation.

  1982cited by this paper
• Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation

  1982cited by this paper
• Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.

  1981cited by this paper
• Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

  1980cited by this paper
• Management of anuric intensive-care patients with arteriovenous hemofiltration

  1980cited by this paper
• Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.

  1979cited by this paper
• Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

  1979cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Association between platelet levels and bleeding events in patients with acute-on-chronic liver failure treated with an artificial liver support system

  2026cites this paper
• Continuous Renal Replacement Therapy

  2019cites this paper
• Differences in CVVH vs. CVVHDF in the management of sepsis-induced acute kidney injury in critically ill patients

  2017cites this paper
• Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis

  2015cites this paper
• Renal Replacement Therapy.

  2015cites this paper
• Hemodynamic improvement after continuous renal replacement therapies: Not only immunomodulation

  2014cites this paper
• Decreased Platelet Count in Patients Receiving Continuous Veno-Venous Hemofiltration: A Single-Center Retrospective Study

  2014cites this paper
• Hemofiltración de alto volumen en shock séptico

  2010cites this paper
• [High volume hemofiltration in septic shock].

  2010cites this paper
• Acute Kidney Injury and Extracorporeal Blood Purification in Sepsis

  2009cites this paper
• Management of sepsis : the PIRO approach

  2009cites this paper
• Multiorganic Dysfunction Syndrome in the Elderly Critically Ill Patient

  2008cites this paper
• The Aging Kidney in Health and Disease

  2008cites this paper
• Citrate Anticoagulation during CVVH in High Risk Bleeding Patients

  2007cites this paper
• Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.

  2007cites this paper
• Citrate anticoagulation during CVVH in high risk bleeding patients.

  2007cites this paper
• Continuous renal replacement in critical illness.

  2007cites this paper
• Endotoxin Adsorption Therapy for Septic Shock Using Polymyxin B‐Immobilized Fibers (PMX): Evaluation by High‐sensitivity Endotoxin Assay and Measurement of the Cytokine Production Capacity

  2006cites this paper
• Pulse High‐Volume Hemofiltration in Critically Ill Patients: A New Approach for Patients with Septic Shock

  2006cites this paper
• Prostacyclin versus Citrate in Continuous Haemodiafiltration: An Observational Study in Patients with High Risk of Bleeding

  2005cites this paper
• Pulse High Volume Hemofiltration: Rationale and Early Clinical Experience

  2005cites this paper
• Multiple organ support therapy for the critically ill patient in intensive care

  2005cites this paper
• Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis.

  2005cites this paper
• High volume hemofiltration in critically ill patients: why, when and how?

  2004cites this paper
• Cystatin C as a Marker of Residual Renal Function during Continuous Hemodiafiltration

  2004cites this paper
• Linee Guida sulla Dialisi. Il trattamento sostitutivo della Insufficienza Renale Acuta nel paziente critico

  2004cites this paper
• Extracorporeal Therapies in Non-Renal Disease: Treatment of Sepsis and the Peak Concentration Hypothesis

  2004cites this paper
• Advances in membrane biology for continuous renal replacement therapy

  2003cites this paper
• Cytokine Removal in Septic Patients with Continuous Venovenous Hemofiltration

  2003cites this paper
• Interpreting the Mechanisms of CRRT in Sepsis: The Peak Concentration Hypothesis

  2003cites this paper
• The role of extracorporeal therapies in sepsis.

  2003cites this paper
• Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis.

  2003cites this paper
• Hemofiltration and Plasmapheresis

  2002cites this paper
• High-Volume Hemofiltration in Sepsis

  2002cites this paper
• High Volume Hemofiltration in Sepsis

  2002cites this paper
• Acute Renal Failure and Multiple Organ Dysfunction in the ICU: From Renal Replacement Therapy (RRT) to Multiple Organ Support Therapy (MOST)

  2002cites this paper
• Coupled Plasma Filtration Adsorption

  2002cites this paper
• Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis.

  2002cites this paper
• A pilot study of coupled plasma filtration with adsorption in septic shock*

  2002cites this paper
• Continuous renal replacement therapy: opinions and evidence.

  2002cites this paper
• The Acute Dialysis Quality Initiative--part V: operational characteristics of CRRT.

  2002cites this paper
• Continuous hemofiltration/hemodiafiltration in critical care.

  2002cites this paper
• Acute Dialysis Quality Initiative Workgroup 5 Operational Characteristics Timothy Bunchman

  2001cites this paper
• Choosing New Adsorbents for Endogenous Ultrapure Infusion Fluid: Performances, Safety and Flow Distribution

  2001cites this paper
• Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis

  2001cites this paper
• Coupled plasma filtration adsorption in the treatment of septic shock.

  2001cites this paper
• Machines for continuous renal replacement therapy.

  2001cites this paper
• Hemodiafiltration with online regeneration of the ultrafiltrate.

  2000cites this paper
• Continuous veno-venous hemofiltration without anticoagulation in high-risk patients

  2000cites this paper
• The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia.

  2000cites this paper
• Coupled plasma filtration‐adsorption in a rabbit model of endotoxic shock

  2000influential citation
• Convection of diffusion in continuous renal replacement therapy for sepsis

  2000cites this paper
• Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?

  1999cites this paper
• Effect of haemofiltration on pathological fibrinolysis due to severe sepsis: a case report.

  1999cites this paper
• Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs.

  1999cites this paper
• Non-renal indications for continuous renal replacement therapy.

  1999cites this paper
• Cytokine removal during continuous hemofiltration in septic patients.

  1999cites this paper
• Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill.

  1999cites this paper
• Insufficienza Renale Acuta Nello Shock Settico: Funzione Cardiaca e Bilancio di Ossigeno Durante Emofiltrazione Continua

  1999cites this paper
• New Perspectives in the Treatment of Acute Renal Failure

  1999cites this paper
• Cellulose triacetate: another membrane for continuous renal replacement therapy.

  1999cites this paper
• CONTINUOUS RENAL REPLACEMENT THERAPY

  1999cites this paper
• Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis

  1999cites this paper
• Continuous versus intermittent renal replacement therapy in the treatment of acute renal failure.

  1998cites this paper
• [Disordered hemostasis related to sepsis and SIRS].

  1998cites this paper
• Hämostasestörungen im Umfeld von Sepsis und SIRS

  1998cites this paper
• Continuous renal replacement therapies: an update.

  1998cites this paper
• Hemofiltration in Children

  1998cites this paper
• Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome.

  1998cites this paper
• Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine.

  1998cites this paper
• A Primer on Continuous Renal Replacement Therapy for Critically Ill Patients

  1998cites this paper
• Continuous plasma filtration coupled with sorbents.

  1998cites this paper
• The Role of Platelet-Activating Factor in the Haemoincompatibility of Haemodialytic Treatments

  1998cites this paper
• Hemodynamics and survival of patients with acute renal failure treated by continuous dialysis with two synthetic membranes.

  1998cites this paper
• [Hemofiltration during severe sepsis or multiorgan failure syndrome].

  1998cites this paper
• Continuous renal replacement therapy: evolution in technology and current nomenclature.

  1998cites this paper
• Cardiac Function and Oxygen Balance in Septic Patients during Continuous Hemofiltration

  1998cites this paper
• Evolution of Hemofiltration

  1998cites this paper
• Non-renal indication of continuous renal replacement therapies

  1998cites this paper
• Removal and generation of inflammatory mediators during continuous renal replacement therapies

  1998cites this paper
• Effets de l'épuration extrarénale continue et discontinue sur les médiateurs de l'inflammation

  1998cites this paper
• Continuous renal replacement therapy in acute renal failure: membranes for CRRT.

  1998cites this paper
• Is circulatory phospholipase A2 removed by continuous hemodiafiltration in septic acute renal failure

  1998cites this paper
• Clearance of inflammatory mediators through continuous renal replacement therapy.

  1997cites this paper
• Influence of continuous hemofiltration on the hemodynamics of trauma patients.

  1997cites this paper
• Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments.

  1997cites this paper
• [Continuous "high flux" dialysis: an effective renal replacement therapy for intensive care patients].

  1997cites this paper
• [Systemic inflammatory reactions to extracorporeal therapy measures (I): Hemodialysis and hemofiltration].

  1997cites this paper
• Il Platelet Activating Factor (PAF), Marcatore Di Biocompatibilità, Nella Dialisi Con Membrane in Poliacrilonitrile

  1997cites this paper
• Hemofiltración continua en pacientes pediátricos en estado critico

  1997cites this paper
• New CRRT systems: impact on dose delivery.

  1997cites this paper
• Should continuous renal replacement therapy be used for 'non-renal' indications in critically ill patients with shock?

  1997cites this paper
• Should continuous renal replacement therapy be used for ‘non-renal’ indications in critically ill patients with shock?

  1997cites this paper
• Pathophysiology, Presentation, and Treatment of Conditions Associated with DIC

  1997cites this paper
• Future technology for continuous renal replacement therapies

  1996cites this paper
• Continuous Renal Replacement Therapies: Evolution Towards a New Era

  1996cites this paper
• Pathophysiologie, Klinik und Therapie intensivmedizinischer Krankheitsbilder mit DIC

  1996cites this paper
• [Use of plasmapheresis in a 62-year-old patient with severe infection].

  1996cites this paper
• Today's technology for continuous renal replacement therapies

  1996cites this paper
• Continuous High Flux Dialysis: An Efficient Renal Replacement

  1996cites this paper